The 1st Essay: Why P · 2·P — PHENOTYPE TO PATHOPHYSIOLOGY ?

Have you searched for it. “Hamburg classification vascular malformations” first? “ISSVA classification vascular anomalies” right after?

You will find a chart. Actually, you will find several charts, and they will not agree with each other in appearance, even when they agree in substance.

HAMBURG GRAPHIC ◈

This is what a mother and father sees at midnight, phone light too bright in a dark room, three days after someone finally said a word she’d never heard before. This is what a father sees, trying to be useful, trying to translate something that was never written for him to read.

We know. We were you. Not a mom or a dad — yet, born rare, mom and dad passing away without answers.

Thirty years ago, there was no internet-easy, no search bar to type into — just a C:/ prompt on green on a DOS-based PC. This, and doctors who didn’t have the answer either, and a birthmark that outlived every explanation offered for it.

The charts exist now. That’s progress. But existing and being readable are not the same thing.

Bam. Here is our synthesis, and why.

Hamburg classifies by origin story — by the developmental moment, somewhere in the earliest weeks of a life not yet born, when a vessel formed the way it wasn’t supposed to. There aren’t many of these origin stories. Roughly twenty. Truncular or extratruncular. Infiltrating or limited. Slow-flow or fast. A short, sturdy alphabet, built to describe how a lesion behaves once it exists — how likely it is to come back after treatment, how deep it runs, what kind of watching it deserves.

From each one of those twenty origin stories, many specific diagnoses can grow. One embryological accident, many possible names for what it becomes. That’s the direction our Hamburg Cross-Reference walks: start small, end at the specific. It exists because a family deserves to hear, early, that the strange new word attached to their child belongs to a family of conditions that share a predictable shape — that “rare” does not mean “unknowable,” only “uncommon enough that you had to go looking for the answer yourself.”

A doctor standing at a bedside does not usually start with embryology. She starts with what she can see and measure — a specific name, a specific presentation, a hundred possible specific names in our own catalog alone. What she needs, fast, is the reverse direction: given this one particular diagnosis, which of Hamburg’s twenty behavior patterns does it belong to? Is this truncular or extratruncular? Will it likely come back after treatment, or was today’s procedure closer to the end of the story than the middle?

Enter ISSVA’s 100 specific names. It is essentially the same map, but walked another way. Names, folded back down into the handful of behavior patterns that actually govern what happens next. Not a different truth from the family’s map — the same truth, entered from the opposite door, because a clinician’s first question and a parent’s first question are rarely the same question, even when the correct answer turns out to be nearly identical, but different enough to matter.

Here is the part that took us the longest to actually see,

. . . though it was always sitting in plain view: these two directions are not two competing systems. They are not even, strictly, two documents. They are one relationship, described from its two ends, and the relationship could not exist any other way.

Biology does not care which direction you read the chart. A capillary malformation with a PIK3CA driver behaves the way it behaves whether you arrived at that fact by asking “what is my child’s diagnosis, and what family does it belong to” or by asking “what did this specific presentation grow from, embryologically, and what should I expect.” Hamburg’s few and the other one hundred are not rivals. They are load-bearing walls holding up the same house from opposite corners — remove either one, and the other stops making full sense on its own. This is not poetic license. It is medical-scientific necessity: origin predicts behavior, and specific identity predicts treatment, and neither question can fully answer the other’s without borrowing from it.

Two maps, it is — one collapsing outward from a small alphabet into a hundred names, one folding a hundred names back down into that same small alphabet. Between them, they answer what this is and what this behaves like.

They do not answer a third, a fourth question,

. . . the one that turns out to matter most once the first shock of a diagnosis has passed: how far does this go? when is similar, different enough to matter?

Not every capillary malformation carries the same weight. An isolated port wine stain and a syndromic one sharing the same visible surface can sit at entirely different points on a spectrum of what’s happening underneath — different depth, different systems involved, different distance between “cosmetic” and “requires a specialist team.” Neither Hamburg’s Embryology nor the catalog of Classifications was built to show these at a glance. Something else had to.

That something is P·2·P — Phenotype to Pathophysiology, a patient, synthesized framework rooted in 42 years misdiagnosed, and 30 years in the hunt for concrete answers. Why? How? What matters? When do these body changes stabilize, get better?

Not a third framework competing with the first two, but a third lens laid over both of them: a relative-complexity ordering, low to high, within each predominant type — capillary, lymphatic, venous, combined — and across them.

Where Hamburg tells you the origin story and the catalog of Classifications tells you the specific name, P·2·P tells you the distance still to travel, when similar is just enough different to matter. It is built because knowing what something is called and knowing how far it reaches turned out, again and again, to be two different pieces of information that families and doctors both needed in the same conversation, and neither existing chart gave them both.

Three lenses, then, not one. Origin, walked outward. Identity, folded back inward. And distance and confounding, laid across both. Look through any one of them alone and you’ll see something true and incomplete. Look through all three together, and something that once looked like eight-point font and forking arrows starts to look like what it actually is: a map somebody finally built for the people who have to live inside the territory it describes.

Here are ours —

. . . three charts, one relationship, and the chart that measures the distance between where a diagnosis starts and where it might actually go. When science is not all the same. When one syndrome becomes three or more. When misdiagnosis or changed diagnosis is a natural consequence of science adapting, learning. When its a patient, their lived experience that sheds light — or at a minimum, begs questions.